1-year, time and materials (t & m) type task order for project management support services for the FDA's center for drug evaluation and research (cder), office of pharmaceutical quality (OPQ).

Ended Awarded Last action

Contract number
75F40125F19002
Awardee
Awarding agency
Obligated
$490

Award facts

Contract value 100% obligated
$490.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Time and Materials
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$291,503
Other Administrative Action P00002 · Correct POP end date of fully terminated, 1-year, time and materials (t & m) type task order for project management support services for the FDA's center for… $0
Terminate for Convenience P00001 · Termination for convenience (complete). GSA memorandum provided to federal government agencies regarding "identification of contracts that may be wasteful,… $0
Original award $291,993

About this award

This is a 1-year, time and materials task order awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The $291,993.20 task order is for project management support services for the FDA's Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ). The task order is issued under the FDA's $100 million Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery Contract, which is set aside for competitive 8(a) businesses. Kaiva Strategies, LLC is certified as an 8(a) joint venture and holds multiple small business certifications, including HUBZone and small disadvantaged business status. The company has a strong track record of supporting critical public health missions for the FDA and the Centers for Disease Control and Prevention (CDC).

Quick answers

Who was awarded contract 75F40125F19002?

75F40125F19002 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on December 16, 2024.

How much is contract 75F40125F19002 worth?

The government has obligated $490 on 75F40125F19002.

Is contract 75F40125F19002 an order under another contract?

Yes. 75F40125F19002 is a delivery order under 75F40123D00021, an indefinite delivery contract.

Was contract 75F40125F19002 competed?

The extent of competition for 75F40125F19002 was full and open competition after exclusion of sources.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award